Binding of Matrix Metalloproteinase Inhibitors to Extracellular Matrix: 3D-QSAR Analysis-Reference-Cited by-同舟云学术

Binding of Matrix Metalloproteinase Inhibitors to Extracellular Matrix: 3D-QSAR Analysis

Published:2008-10 Issue:4 Volume:72 Page:237-248
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:

Author:

Zhang Yufen,Lukacova Viera,Bartus Vladimir,Nie Xiaoping,Sun Guorong,Manivannan Ethirajan,Ghorpade Sandeep R.,Jin Xiaomin,Manyem Shankar,Sibi Mukund P.,Cook Gregory R.,Balaz Stefan

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Reference30 articles.

1. Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy;Overall;Nat Rev Cancer,2006

2. Towards third generation matrix metalloproteinase inhibitors for cancer therapy;Overall;Br J Cancer,2006

3. Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases;Bernardo;J Biol Chem,2002

4. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2);Rosenblum;J Biol Chem,2003

5. Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518;Crul;Cancer Chemother Pharmacol,2002

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using 3D in vitro cell culture models in anti-cancer drug discovery;Expert Opinion on Drug Discovery;2021-04-26

2. Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates;mAbs;2017-05-02

3. Composition and Function of the Interstitial Fluid;Protein Science;2016-08-04

4. Decellularized skeletal muscle as an in vitro model for studying drug-extracellular matrix interactions;Biomaterials;2015-09

5. Machine Learning Methods for Property Prediction in Chemoinformatics: Quo Vadis?;Journal of Chemical Information and Modeling;2012-05-25